Condition: Hypertension · Sponsor: Istituto Auxologico Italiano
The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension. The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry. The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI (diastolic pressure-time index), i.e. the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase, and the SPTI ( systolic pressure-time index), i.e. the area under the carotid pressure curve during the systolic phase. The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database.
This description comes directly from the study's public registry record.
Paolo Salvi, MD · +390261911 · p.salvi@auxologico.it
Always discuss trial participation with your own doctor first.
| Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi" | Mascalucia, Catania, Italy | Recruiting |
| Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa "Anna Maria Pirrelli", Università degli Studi di Bari "Aldo Moro". Policlinico Consorziale di Bari | Bari, Italy | Recruiting |
| Istituto Auxologico Italiano IRCCS | Milan, Italy | Recruiting |
| Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia | Reggio Emilia, Italy | Recruiting |
| Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di Trieste | Trieste, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06309511